2025-12-13 - Analysis Report
Okay, let's break down the analysis of Schrodinger Inc. (SDGR).

**Company Overview:** Schrodinger Inc. is a company focused on developing software-based solutions for drug discovery and materials science.

**1. Return Rate Comparison:**

*   **SDGR Cumulative Return:** -55.26%
*   **VOO (S&P 500) Cumulative Return:** 70.53%
*   **Divergence:** -125.2 (Relative Divergence: 1.1)

**Analysis:** SDGR has significantly underperformed the S&P 500. The divergence of -125.2 indicates a substantial difference in returns. A relative divergence of 1.1 suggests that the current divergence is near the minimum end of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2020-2022  | -70.0% | 78.2% | -76.0% | 0.0 | 1.4 |
| 2021-2023  | -57.0% | 81.0% | -59.0% | -0.0 | 2.6 |
| 2022-2024  | 6.0% | 81.0% | -14.0% | -0.0 | 1.4 |
| 2023-2025  | -4.0% | 82.6% | -70.0% | -0.0 | 1.3 |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  The CAGR is negative for all periods except 2022-2024, indicating poor overall growth.
*   **MDD (Maximum Drawdown):**  High MDD values across all periods suggest significant volatility and risk.
*   **Alpha:**  Negative alpha indicates that SDGR has underperformed relative to its benchmark (likely the market) after accounting for risk.
*   **Beta:** A Beta near 0.0 indicates that SDGR stock price is very unrelated to general market fluctuations.
*   **Cap(B):** The market capitalization in billions of dollars is relatively small and has fluctuated.

**2. Recent Stock Price Fluctuations:**

*   **Current Close:** 17.94
*   **Last-market:** {'price': 18.05, 'previousClose': 18.13, 'change': -0.44}
*   **5-day SMA:** 17.91
*   **20-day SMA:** 17.39
*   **60-day SMA:** 19.25

**Analysis:** The 5-day SMA is above the 20-day SMA, suggesting a short-term upward trend. However, the 60-day SMA is significantly higher, indicating that the longer-term trend might still be downward.

**3. Index Indicators:**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment)
*   **RSI (Relative Strength Index):** 61.38
*   **PPO (Percentage Price Oscillator):** 1.03
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (58 shares - Very Safe - MRI:0.90) Monthly invest 1.4% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Relative Divergence Change (20 days):** 0.4 (+) (단기상승 - Short-term Increase)
*   **Expected Return (%):** -5818.7%

**Analysis:**

*   **MRI:** Suggests a medium level of investment risk.
*   **RSI:** 61.38 indicates the stock is approaching overbought territory (above 70 is generally considered overbought).
*   **PPO:** A positive PPO suggests a short-term upward trend.
*   **Hybrid Signal:** Recommends a full investment with monthly additions.
*   **Divergence Change:**  The recent increase in relative divergence suggests a short-term upward trend relative to the comparison stock.
*   **Expected Return:** The extremely negative expected return is a major red flag. This suggests analysts anticipate a significant decline in the stock's value. The fluctuation issue (sharp rebound, sharp decline) needs to be considered.

**4. Recent News & Significant Events:**

*   **Positive Headlines:** Several headlines suggest potential upside, including analyst target price increases, ARK Investment's acquisition of shares, and identification of hidden value.
*   **Tactical Trading Focus:** Some articles focus on tactical trading, suggesting the stock may be subject to short-term speculation.
*   **Strength Seen:** An article notes a 13.8% jump, indicating recent positive price action.

**Analysis:** The news is mixed. While some headlines suggest potential growth and analyst optimism, others highlight the stock's suitability for tactical trading, implying volatility.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy (Mean: 1.67)
*   **Target Price:** Avg: 27.22 / High: 33.00 / Low: 18.00

**Analysis:** Analysts, on average, have a "Buy" rating for SDGR and expect the price to increase, with an average target price of $27.22. However, the low target price of $18.00 is close to the current price.

**5. Recent Earnings Analysis:**

| 날짜       | EPS    | 매출    |
|------------|--------|---------|
| 2025-11-05 | -0.45  | 0.05 B$ |
| 2025-08-06 | -0.59  | 0.05 B$ |
| 2025-05-07 | -0.82  | 0.06 B$ |
| 2024-11-12 | -0.52  | 0.04 B$ |
| 2025-11-05 | -0.52  | 0.04 B$ |

**Analysis:** The company has consistently reported negative Earnings Per Share (EPS), indicating unprofitability. Revenue has remained relatively stable.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-09-30 | $0.05B  | 51.61%        |
| 2025-06-30 | $0.05B  | 47.77%        |
| 2025-03-31 | $0.06B  | 52.26%        |
| 2024-12-31 | $0.09B  | 72.61%        |
| 2024-09-30 | $0.04B  | 50.24%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-09-30 | $0.32B  | -10.21% |
| 2025-06-30 | $0.34B  | -12.59% |
| 2025-03-31 | $0.37B  | -16.01% |
| 2024-12-31 | $0.42B  | -9.54%  |
| 2024-09-30 | $0.45B  | -8.49%  |

**Analysis:**

*   **Revenue:** Revenue is relatively low and fluctuating.
*   **Profit Margin:** While profit margins are high, they are applied to a relatively small revenue base.
*   **Equity:** Equity has been decreasing, which is concerning.
*   **ROE (Return on Equity):** Negative ROE indicates the company is not generating profits from shareholder equity.

**7. Comprehensive Analysis (Summary):**

SDGR presents a mixed investment picture.

*   **Negatives:**
    *   Significant underperformance compared to the S&P 500.
    *   Consistently negative EPS and ROE, indicating unprofitability.
    *   High MDD, suggesting high volatility.
    *   Decreasing equity.
    *   Extremely negative expected return.
*   **Positives:**
    *   Recent positive price action.
    *   "Buy" consensus from analysts with a target price above the current price.
    *   High profit margins (although on a small revenue base).
    *   Positive divergence change suggesting a short-term uptrend.

**Conclusion:**

While some indicators suggest potential short-term gains, the long-term financial performance and extremely negative expected return raise significant concerns about SDGR's investment viability. The company is unprofitable, and its stock has underperformed significantly. The analyst buy ratings and positive news headlines should be viewed with caution in light of the underlying financial data. A more in-depth investigation of the company's long-term strategy and path to profitability is warranted before considering investment.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.